Author:
Ajoolabady Amir,Pratico Domenico,Henninger Nils,Tuomilehto Jaakko,Klionsky Daniel J.,Ren Jun
Publisher
Springer International Publishing
Reference76 articles.
1. Ahola S, Mejías PR, Hermans S, Chandragiri S, Giavalisco P, Nolte H, Langer T (2022) OMA1-mediated integrated stress response protects against ferroptosis in mitochondrial cardiomyopathy. Cell Metab 34(11):1875–1891.e1877
2. Ajoolabady A, Aslkhodapasandhokmabad H, Libby P, Tuomilehto J, Lip GY, Penninger JM, Richardson DR, Tang D, Zhou H, Wang S (2021) Ferritinophagy and ferroptosis in the management of metabolic diseases. Trends Endocrinol Metab 32(7):444–462
3. Baba Y, Higa JK, Shimada BK, Horiuchi KM, Suhara T, Kobayashi M, Woo JD, Aoyagi H, Marh KS, Kitaoka H (2018) Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes. Am J Phys Heart Circ Phys 314(3):H659–H668
4. Berdoukas V, Coates TD, Cabantchik ZI (2015) Iron and oxidative stress in cardiomyopathy in thalassemia. Free Radic Biol Med 88:3–9
5. Bi Y, Ajoolabady A, Demillard LJ, Yu W, Hilaire ML, Zhang Y, Ren J (2021) Dysregulation of iron metabolism in cardiovascular diseases: from iron deficiency to iron overload. Biochem Pharmacol 190:114661